A US-based medical artificial intelligence startup VoxelCloud has just a closed US$15 million in Series A round, led by Chinese Internet giant Tencent Holdings Ltd together with named US investors including
Shanghai United Imaging Healthcare. A major China medical imaging device maker, recently closed a $500 million A financing from large China investors. It is by far the largest medical device
Fotona Expands into China and Asia with AGIC Acquisition AGIC is an Asia-Europe cross-border growth equity firm and Fotona is a European manufacturer of high performance lasers for medical, dental
Fidelity’s Eight Roads Venture Launches $250M China Healthcare Fund Fidelity’s investment branch Eight Roads Ventures (formerly Fidelity Growth Partners) announced its dedicated healthcare fund for China, reinforcing its acceleration into
A Shanghai JV Is Created To Invest In International Medical Device Companies The Trendlines Group is an Israeli medical technology incubator that focuses on developing and commercializing medical and agricultural
Vixiar Medical, a spin-off from Johns Hopkins, recently completely its seed round funding. The USD $1.5million investment was provided by the Abell Foundation and TEDCO, as well as Kacero Holdings,
C-Bridge Capital, a China private equity firm with a life science focus, closed its second fund, C-Bridge Healthcare Fund II, at its $400 million cap. C-Bridge plans to invest in
Rapid Medical, an Israeli company focused on the development of neurovascular interventional devices, has completed a US$9 million series B financing to advance the commercialization of the company’s minimally invasive
BGI Genomics is planning for its IPO in China. As the contract sequencing and diagnostics divisions of China’s genomic company BGI, BGI Genomics expects to raise $250 million from this
China’s Ping An Insurance Group, its largest insurer by market value, announced a plan to launch a $1 billion international fund that will invest in fin-tech and healthcare startups. In
China Medical Device Market News: China-based Hebron Technology Co Ltd and Ukrainian firm Research and Product Complex BioPromin Ltd (BioPromin) are investing up to $50 million for a joint venture
Epic Sciences of San Diego closed a $40 million Series D financing led by Hong Kong’s Hermed Capital. Epic is developing a portfolio of blood-based tests that predict drug response
Email: info@chinameddevice.com
Phone: 978-390-4453
Office:
800 Turnpike St. Ste 300
North Andover, MA, 01845
